ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
cypionate dose protocols for woman
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 263300" data-attributes="member: 13851"><p>Again the point I am trying to stress here!</p><p></p><p>As I stated previously.</p><p></p><p>Any women running T levels of a healthy young male let alone T levels well beyond will experience virilization/masculinization whether dysphonia. hirsutism, clitoromegaly, menstrual irregularities, reduced breast size, changes in skin texture (poor size, oily skin, acne), <strong><em>it is a given and to what degree depends on the individual.</em></strong></p><p></p><p>Give a women testosterone in high enough doses to push her levels well beyond the female range and <strong><em>it is a given that there is going to be some degree of virilization/masculinization.</em></strong></p><p></p><p>This is a common when treating FTM with doses of testosterone which push T levels into the male physiologic range.</p><p></p><p>Testosterone is highly androgenic and will cause virilization/masculinization of a female when the levels are pushed high enough!</p><p></p><p>No claims being made here.</p><p></p><p>Just to be clear it is not just dieting/low body fat levels as androgens have a direct impact on the physiology of female breast tissue.</p><p></p><p></p><p></p><p></p><p><strong>Reduced Breast Size </strong></p><p></p><p><em><strong>Anabolic/androgenic steroids can inhibit the growth supporting effects of estrogen on mammary tissues, and may cause a visible reduction in breast size (breast atrophy). <u>Androgen use in females has specifically been shown to cause a reduction in glandular tissue size, and to promote an increase in fibrous connective tissue</u>.236</strong> These physiological changes are similar to those noted after menopause, when female sex steroids are very low.<strong> <u>Reductions in breast size produced by AAS may be very persistent after the discontinuance of drug intake, as there can be substantial local tissue remodeling under excess androgen influence</u>.</strong> <strong>Women are warned of the potential for substantial physical changes in the breasts with anabolic/androgenic steroid abuse.</strong></em></p><p></p><p></p><p></p><p><strong>Enlarged Clitoris (Clitoromegaly) </strong></p><p></p><p><em>The male and female reproductive systems differentiate and develop under the influence of estrogen and testosterone.<strong> Even as an adult, the female reproductive system remains developmentally responsive to male sex hormones</strong>. <strong>Anelevation of the androgen level in women may stimulate the growth of the clitoris (clitoral hypertrophy). <u>If androgen levels are not abated quickly this may lead to virilization of the external genitalia, characterized by clinically abnormal enlargement of the clitoris (clitoromegaly)</u>. <u>With clitoromegaly, the clitoris may begin to resemble a small penis, and may even visibly enlarge during sexual arousal (erection)</u>. <u>In more serious cases its association to a male penis can be very striking and clear</u>.</strong> Clitoromegaly can be a very embarrassing condition, usually prompting swift intervention when its onset is noticed. </em></p><p><em></em></p><p><em>Clitoromegaly is most commonly seen as a congenital disorder, <strong>although it may be caused by anabolic/androgenic steroid administration </strong>or other pathology in adulthood (acquired clitoromegaly). <strong>As a virilizing side effect, clitoromegaly tends to occur in a dose-dependant (androgenicity-dependent) manner. As such, higher doses and more androgenic substances (such as testosterone, trenbolone, and methandrostenolone) are more likely to trigger its onset. Primarily anabolic steroids such as nandrolone, stanozolol, and oxandrolone are less androgenic and virilizing, and favored for the treatment of women for this reason.</strong> <strong>Clitoromegaly caused by steroid use is both avoidable and progressive.</strong> <strong>Mitigating excess androgenic action early when it is noticed is the most fundamental part of treatment.</strong> <strong><u>Reversal of significantly developed tissue, however, will require reconstructive surgery (clitoroplasty)</u>.233 Special care should be taken to preserve the dorsal and ventral neurovascular bundles and normal tissue sensation.234</strong></em></p><p></p><p></p><p></p><p></p><p><strong>A photograph of distinct clitoromegaly. <u>Here, the clitoris begins to resemble a penis-like structure under androgen influence</u>. <u>If left unabated, this may progress to a more defined phallic abnormality</u>. Source: Copcu et al. Reproductive Health 2004 1:4 doi:10.1186/1742-4755-1-</strong></p><p><strong>[ATTACH=full]36345[/ATTACH]</strong></p><p><em><strong> *Here, the clitoris begins to resemble a penis-like structure under androgen influence. </strong></em><strong><em>If left unabated, this may progress to a <u>more defined phallic abnormality</u></em></strong></p><p></p><p></p><p>Yes this would be what we call a micro-penis which can happen in some women especially when they abuse testosterone/ highly androgenic AAS!</p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p><strong>Cessation of Menstruation</strong></p><p></p><p><em>As with facial hair, one of the most sought-after effects of testosterone therapy is the <strong>cessation of menstruation, which can be an unpleasant reminder of the presence of female body parts.</strong> In a study27 of 138 transgender men who took three different doses of intramuscular testosterone enanthate ranging from 125 mg every 2 weeks to 250 mg every 2 weeks,<strong> cessation of menstruation was noted by 86–97% of participants by 6 months.</strong> In a study of 45 transgender men randomly assigned either intramuscular testosterone esters, testosterone gel, or intramuscular testosterone undecanoate,16 time to amenorrhoea ranged from 30 to 41 weeks, with all participants reporting amenorrhoea by 1 year</em></p><p></p><p><strong><em>*Testosterone therapy typically induces changes to the vagina, endometrium, and ovaries</em></strong></p><p></p><p></p><p></p><p></p><p></p><p></p><p>This sums up what I was trying to stress here!</p><p></p><p><em><strong>*The goal of masculinizing hormone therapy is the development of male secondary sex characteristics, and suppression/minimization of female secondary sex characteristics</strong></em></p></blockquote><p></p>
[QUOTE="madman, post: 263300, member: 13851"] Again the point I am trying to stress here! As I stated previously. Any women running T levels of a healthy young male let alone T levels well beyond will experience virilization/masculinization whether dysphonia. hirsutism, clitoromegaly, menstrual irregularities, reduced breast size, changes in skin texture (poor size, oily skin, acne), [B][I]it is a given and to what degree depends on the individual.[/I][/B] Give a women testosterone in high enough doses to push her levels well beyond the female range and [B][I]it is a given that there is going to be some degree of virilization/masculinization.[/I][/B] This is a common when treating FTM with doses of testosterone which push T levels into the male physiologic range. Testosterone is highly androgenic and will cause virilization/masculinization of a female when the levels are pushed high enough! No claims being made here. Just to be clear it is not just dieting/low body fat levels as androgens have a direct impact on the physiology of female breast tissue. [B]Reduced Breast Size [/B] [I][B]Anabolic/androgenic steroids can inhibit the growth supporting effects of estrogen on mammary tissues, and may cause a visible reduction in breast size (breast atrophy). [U]Androgen use in females has specifically been shown to cause a reduction in glandular tissue size, and to promote an increase in fibrous connective tissue[/U].236[/B] These physiological changes are similar to those noted after menopause, when female sex steroids are very low.[B] [U]Reductions in breast size produced by AAS may be very persistent after the discontinuance of drug intake, as there can be substantial local tissue remodeling under excess androgen influence[/U].[/B] [B]Women are warned of the potential for substantial physical changes in the breasts with anabolic/androgenic steroid abuse.[/B][/I] [B]Enlarged Clitoris (Clitoromegaly) [/B] [I]The male and female reproductive systems differentiate and develop under the influence of estrogen and testosterone.[B] Even as an adult, the female reproductive system remains developmentally responsive to male sex hormones[/B]. [B]Anelevation of the androgen level in women may stimulate the growth of the clitoris (clitoral hypertrophy). [U]If androgen levels are not abated quickly this may lead to virilization of the external genitalia, characterized by clinically abnormal enlargement of the clitoris (clitoromegaly)[/U]. [U]With clitoromegaly, the clitoris may begin to resemble a small penis, and may even visibly enlarge during sexual arousal (erection)[/U]. [U]In more serious cases its association to a male penis can be very striking and clear[/U].[/B] Clitoromegaly can be a very embarrassing condition, usually prompting swift intervention when its onset is noticed. Clitoromegaly is most commonly seen as a congenital disorder, [B]although it may be caused by anabolic/androgenic steroid administration [/B]or other pathology in adulthood (acquired clitoromegaly). [B]As a virilizing side effect, clitoromegaly tends to occur in a dose-dependant (androgenicity-dependent) manner. As such, higher doses and more androgenic substances (such as testosterone, trenbolone, and methandrostenolone) are more likely to trigger its onset. Primarily anabolic steroids such as nandrolone, stanozolol, and oxandrolone are less androgenic and virilizing, and favored for the treatment of women for this reason.[/B] [B]Clitoromegaly caused by steroid use is both avoidable and progressive.[/B] [B]Mitigating excess androgenic action early when it is noticed is the most fundamental part of treatment.[/B] [B][U]Reversal of significantly developed tissue, however, will require reconstructive surgery (clitoroplasty)[/U].233 Special care should be taken to preserve the dorsal and ventral neurovascular bundles and normal tissue sensation.234[/B][/I] [B]A photograph of distinct clitoromegaly. [U]Here, the clitoris begins to resemble a penis-like structure under androgen influence[/U]. [U]If left unabated, this may progress to a more defined phallic abnormality[/U]. Source: Copcu et al. Reproductive Health 2004 1:4 doi:10.1186/1742-4755-1- [ATTACH type="full" alt="Screenshot (27756).png"]36345[/ATTACH][/B] [I][B] *Here, the clitoris begins to resemble a penis-like structure under androgen influence. [/B][/I][B][I]If left unabated, this may progress to a [U]more defined phallic abnormality[/U][/I][/B] Yes this would be what we call a micro-penis which can happen in some women especially when they abuse testosterone/ highly androgenic AAS! [B]Cessation of Menstruation[/B] [I]As with facial hair, one of the most sought-after effects of testosterone therapy is the [B]cessation of menstruation, which can be an unpleasant reminder of the presence of female body parts.[/B] In a study27 of 138 transgender men who took three different doses of intramuscular testosterone enanthate ranging from 125 mg every 2 weeks to 250 mg every 2 weeks,[B] cessation of menstruation was noted by 86–97% of participants by 6 months.[/B] In a study of 45 transgender men randomly assigned either intramuscular testosterone esters, testosterone gel, or intramuscular testosterone undecanoate,16 time to amenorrhoea ranged from 30 to 41 weeks, with all participants reporting amenorrhoea by 1 year[/I] [B][I]*Testosterone therapy typically induces changes to the vagina, endometrium, and ovaries[/I][/B] This sums up what I was trying to stress here! [I][B]*The goal of masculinizing hormone therapy is the development of male secondary sex characteristics, and suppression/minimization of female secondary sex characteristics[/B][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
cypionate dose protocols for woman
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top